Related Experiment Video

Updated: Oct 13, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.5K

miR-34a-5p blocks cervical cancer growth and migration by downregulating CDC25A

Tao Jiang1, Hongyan Cheng

  • 1Department of Obstetrics and Gyneocology, Suizhou Hospital, Hubei University of Medicine, Suizhou, Hubei Province, China.

Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|November 11, 2021
PubMed
Abstract

Insights

MicroRNA-34a-5p (miR-34a-5p) inhibits cervical cancer (CC) progression by downregulating CDC25A. This finding offers potential therapeutic targets for CC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cervical cancer (CC) remains a significant global health challenge.
  • Understanding the molecular mechanisms driving CC progression is crucial for developing effective therapies.

Purpose of the Study:

  • To elucidate the regulatory relationship between microRNA-34a-5p (miR-34a-5p) and CDC25A in cervical cancer.
  • To define the role of this interaction in the biological behavior of CC cells.

Main Methods:

  • Quantitative analysis of miR-34a-5p and CDC25A expression in 68 CC tissues and matched controls.
  • In vitro studies using CC cell lines (HeLa, SiHa) involving gene transfection and dual-luciferase reporter assays.
  • Assessment of cell proliferation, migration, and apoptosis.

Main Results:

  • CC tissues exhibited lower miR-34a-5p and higher CDC25A levels.
  • Overexpression of miR-34a-5p or inhibition of CDC25A suppressed CC cell growth and migration, increasing apoptosis.
  • miR-34a-5p directly targets CDC25A, showing a negative correlation in CC tissues.
  • CDC25A overexpression counteracted the inhibitory effects of miR-34a-5p.

Conclusions:

  • miR-34a-5p functions as a tumor suppressor in cervical cancer by regulating CDC25A.
  • This miR-34a-5p/CDC25A axis plays a critical role in mediating CC cell growth, migration, and other malignant behaviors.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.1K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.7K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.5K